01093 CSPC PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.19X | Oper Margin | 18.8% |
|---|---|---|---|
| LT Debt/Equity | 0.5% | Net Margin | 14.9% |
| Total Debt/Equity | 1.9% | Return on Equity | 11.7% |
| Price/Book | 3.03X | Return on Assets | 8.3% |
| (HKD 9.710) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 4,321.17 | 4,602.87 | 6,473.58 | 6,829.67 | 6,855.70 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -6.1 | -28.9 | -5.2 | -0.4 | +12.0 |
| Earnings Per Share (HKD) | 0.378 | 0.392 | 0.545 | 0.573 | 0.574 |
| Earnings Per Share Growth (%) | -3.5 | -28.1 | -4.9 | -0.1 | +12.0 |
| Dividend Per Share (HKD) | 0.290 | 0.260 | 0.280 | 0.210 | 0.180 |
| P/E* (X) | 25.67 | 24.76 | 17.81 | 16.94 | 16.93 |
| Yield (%) | 2.99 | 2.68 | 2.88 | 2.16 | 1.85 |
| Dividend Share (%) | 76.66 | 66.31 | 51.35 | 36.64 | 31.39 |
| Book NAV (HKD) | 3.205 | 2.948 | 3.075 | 2.837 | 2.660 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 26,006 | 29,009 | -10.4 | 31,450 |
| Operating Result | 4,861 | 5,668 | -14.2 | 7,411 |
| Associates | -52.445 | -89.474 | -41.4 | -54.196 |
| Profit Before Taxation | 4,808 | 5,579 | -13.8 | 7,389 |
| Taxation | 931.727 | 1,240 | -24.9 | 1,317 |
| Profit /( Loss) After Taxation | 3,876 | 4,339 | -10.7 | 6,073 |
| Minority Interests | -5.718 | 10.79 | -153.0 | 199.368 |
| Net Profit | 3,882 | 4,328 | -10.3 | 5,873 |
| Earnings Per Share () | 0.3783 | 0.3921 | -3.5 | 0.5453 |
| Dividend Per Share () | 0.2900 | 0.2600 | +11.5 | 0.2800 |
| Announcement Date | 2026-03-25 | 2025-03-28 | NA | 2024-03-20 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
